Targeted Medical Pharma, Inc. (TRGM)
OTCMKTS · Delayed Price · Currency is USD
0.000007
+0.000006 (600.00%)
At close: May 14, 2026
Targeted Medical Pharma Market Cap
Targeted Medical Pharma has a market cap or net worth of $206 as of June 3, 2026. Its market cap has decreased by -99.96% in one year.
Market Cap
206.00
Enterprise Value
n/a
Revenue
5.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since October 17, 2012, Targeted Medical Pharma's market cap has decreased from 110.25M to 206.00, a decrease of -100.00%. That is a compound annual growth rate of -62.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 206.00 | -93.01% |
| Dec 27, 2021 | 2.95K | -99.33% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Australis Capital | 254.00 |
| Cryomass Technologies | 240.00 |
| Emerging World Pharma | 239.00 |
| Green Growth Brands | 238.00 |
| Wayland Group | 237.00 |
| Khiron Life Sciences | 232.00 |
| RavenQuest BioMed | 182.00 |
| Isracann Biosciences | 177.00 |